Wafik S. El-Deiry: Polygenic Risk Score Study for Prostate Cancer Screening Published in NEJM
Wafik S. El-Deiry, Associate Dean for Oncologic Sciences at the Warren Alpert Medical School and Director of the Legorreta Cancer Center at Brown University, shared a post on LinkedIn about a paper by Jana McHugh et al. published in NEJM:
“Assessment of a Polygenic Risk Score in Screening for Prostate Cancer. ‘Using germline DNA extracted from saliva, we derived polygenic risk scores from 130 variants known to be associated with an increased risk of prostate cancer’. “
Title: Assessment of a Polygenic Risk Score in Screening for Prostate Cancer
Authors: Jana McHugh, Elizabeth Bancroft, Edward Saunders, Mark Brook, Eva McGrowder, Sarah Wakerell, Denzil James, Reshma Rageevakumar, Barbara Benton, Natalie Taylor, Kathryn Myhill, Matthew Hogben, Netty Kinsella, Aslam Sohaib, Declan Cahill, Stephen Hazell, Samuel Withey, Naami Mcaddy, Elizabeth Page, Andrea Osborne, Sarah Benafif, Ann-Britt Jones, Dhruv Patel, Dean Huang, Kaljit Kaur, Bradley Russell, Ray Nicholson, Fionnuala Croft, Justyna Sobczak, Claire McNally, Fiona Mutch, Samantha Bennett, Lenita Kingston, Questa Karlsson, Tokhir Dadaev, Sibel Saya, Susan Merson, Angela Wood, Nening Dennis, Nafisa Hussain, Alison Thwaites, Syed Hussain, Imran Rafi, Michelle Ferris, Pardeep Kumar, Nicholas James, Nora Pashayan, Zsofia Kote-Jarai, Rosalind Eeles.
You can read the Full Article in NEJM.
More posts featuring Wafik S. El-Deiry.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023